Dehaier Medical Syst (DHRM) 1.62 $DHRM
Dehaier Medical Systems Ltd. Cooperates with China Sciences Group (Holding) Co., Ltd. to Enter China's Elderly Sleep Apnea Market
PR Newswire - Thu Jul 07, 9:00AM CDT
Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier" or the "Company"
, which develops, markets and sells medical devices and wearable sleep respiratory products in China, announced on July 5, 2016 that it is partnering with China Sciences Group (Holding) Co., Ltd. ("China Sciences" to enter the Chinese pension and health industry by providing Dehaier's products through China Sciences' elder care platform. In connection with this announcement, Dehaier, China Sciences and another supplier, Chia Tai Pharmaceutical Group ("Chia Tai" , have signed a strategic cooperation agreement to launch the "Elderly Sleep Apnea Comprehensive Disease Solution Project" (the "Project" . The Project will leverage China Sciences' "Hui Kang" cloud-based health management platform to provide Dehaier's and Chia Tai's medical devices to the elderly.
DHRM: 1.62 (-0.06)
Dehaier Medical Announces Receipt of the Nasdaq Notification Letter
PR Newswire - Mon May 23, 4:00PM CDT
Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier Medical" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China and international markets, today announced that on May 18, 2016, the Listing Qualifications department of the Nasdaq Stock Market ("Nasdaq" sent the Company a notification letter (the "Nasdaq Letter" indicating that, as a result of the Company's failure to file its annual report on Form 20-F for the year ended December 31, 2015, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule" , which requires timely filing of periodic reports with the Securities and Exchange Commission.
DHRM: 1.62 (-0.06)
Dehaier Medical Receives US$20 Million Strategic Investment from Liaison Interactive
PR Newswire - Thu Apr 28, 8:52AM CDT
Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier Medical" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China and international markets, today announced that it entered into a definitive securities purchase agreement (the "Agreement" with Hangzhou Liaison Interactive Information Technology Co. Ltd. ("Liaison Interactive" or the "Purchaser" , a publicly listed company on the Shenzhen Stock Exchange (Trading Ticker: 002280) pursuant to which the Liaison Interactive has agreed to purchase 11,111,111 restricted common shares of the Company (the "Shares" for an aggregate of US$20,000,000 (the "Purchase Price" . The Purchase Price is US$1.80 per share, which represents a 35% premium to Dehaier Medical's closing price of $1.33 on April 27, 2016.
DHRM: 1.62 (-0.06)
Dehaier Medical Systems Announces Preliminary Full Year 2015 Operating Results
PR Newswire - Fri Apr 08, 6:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China and international markets, today announced its selected preliminary, unaudited results for the fiscal year ended December 31, 2015.
DHRM: 1.62 (-0.06)
Dehaier Medical Announces Corporate Restructuring Plan
PR Newswire - Fri Feb 05, 5:00AM CST
Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier Medical" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China and international markets, today announced its corporate and business restructuring plan which aims to concentrate the Company's resources to develop its mobile health business, including wearable sleep respiratory business and to focus more on its major businesses. As of this announcement, the Company has officially launched the business and corporate restructuring process.
DHRM: 1.62 (-0.06)
Dehaier Medical Announces the Results of 2015 Annual General Meeting
PR Newswire - Thu Dec 31, 5:00AM CST
Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier Medical" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China and international markets, today announced the results of its 2015 annual general meeting of shareholders. The meeting, which was originally scheduled for December 29, 2015, was adjourned to 9:00 p.m., Eastern Standard Time, on Wednesday, December 30, 2015 in order to meet quorum requirements.
DHRM: 1.62 (-0.06)
Continuous Positive Airway Pressure Devices Market 2016-2020
M2 - Mon Dec 07, 3:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/fdxm3v/continuous) has announced the addition of the "Continuous Positive Airway Pressure Devices Market 2016-2020" report to their offering. The global continuous positive airway pressure devices market is just budding and offers high growth opportunity, and hence is expected to progress with steady growth, posting a CAGR of nearly 7% during the forecast period. One of the major drivers of the market is high prevalence of sleep disorders. It is estimated that over 350 million people worldwide suffer from sleep apnea. Thus, the increasing awareness of sleep apnea and associated comorbid conditions such as high blood pressure, and obesity have led to increased demand for sleep apnea diagnostic and therapeutic devices. Similarly, advances in technology such as improved mask design, oral appliances, and use of oxygen devices are expected to provide support to continuous positive airway pressure users. A CPAP device is used to maintain a continuous level of PAP and is used to treat preterm babies whose lungs have not yet fully developed. CPAP devices comply with all age groups and are cost-effective, simple, and easy to use. This segment dominated the market with total market share of nearly 56% in 2015. The continuous positive airway pressure devices market is currently dominated by the Americas, accounting for a market share of almost 59%, followed by the EMEA region and the APAC region. In the Americas, the US was the largest revenue contributor because of the increased diagnosis of sleep apnea in patients. Key Topics Covered: PART 01: Executive summary PART 02: Scope of the report PART 03: Market research methodology PART 04: Introduction PART 05: Sleep apnea: An overview PART 06: Diseases linked to sleep apnea PART 07: Market landscape PART 08: Market segmentation by product type PART 09: Global CPAP devices market PART 10: Global CPAP accessories market PART 11: Geographical segmentation PART 12: Market drivers PART 13: Impact of drivers PART 14: Market challenges PART 15: Impact of drivers and challenges PART 16: Market trends PART 17: Vendor landscape PART 18: Key vendor analysis - ResMed - Philips Healthcare - Fisher & Paykel - 3B Medical - Apex Medical - Apria Healthcare - Armstrong Medical - BMC Medical - Bremed - Cardinal Health - Curative Medical - Dehaier Medical Systems - DeVilbiss Healthcare - Drager Medical - Genstar Technologies - Hans Rudolph - Heinen Lowenstein - Hersill - Heyer Medical - HOFFRICHTER GmbH - InnoMed Technologies - Intersurgical - Invacare - Medtronic - PAHSCO - Penlon - Pneumocare - Pulmodyne - Sleepnet - Smiths Medical - SOMNETICS - Sturdy Industrial - Weinmann Gerate fur Medizin. For more information visit http://www.researchandmarkets.com/research/fdxm3v/continuous
DHRM: 1.62 (-0.06), MDT: 88.36 (+0.87), IVC: 12.85 (+0.28)
Dehaier Medical Appoints Xiaoguang Shen to the Company's Board of Directors
PR Newswire - Tue Dec 01, 5:30AM CST
Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier Medical" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China and international markets, today announced that it has appointed Xiaoguang Shen to the Company's Board of Directors. Mr. Shen will replace Yunxiang ("Phil" Fan and will serve his term until the meeting of the shareholders of the Registrant in 2015. Dehaier Medical's Board will remain at five members, with three independent directors.
DHRM: 1.62 (-0.06)
Dehaier Medical Announces Date of Its 2015 Annual Meeting of Shareholders
PR Newswire - Mon Oct 26, 5:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier Medical" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China and international markets, today announced its Annual Meeting of Shareholders will be held on December 29, 2015, at its executive offices at Suite 501, Jiuzhou Plaza, 83 Fuxing Road, Haidian District, Beijing, 100856, People's Republic of China. The record date for the Annual Meeting is November 23, 2015. The Company expects to mail its definitive proxy statement to all shareholders of record on or about November 25, 2015.
DHRM: 1.62 (-0.06)
Dehaier Wins Medical Equipment Procurement Bid Financed by China Development Bank
PR Newswire - Mon Oct 19, 5:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it has won a medical device distribution bid for a new rural healthcare construction project supported by China Development Bank Corp ("CDB" . According to the agreement, Dehaier will provide its proprietary C-arm X-Ray machine and defibrillator monitor to Dongsheng Hospital of Ordos, Inner Mongolia. The procurement project is funded by CDB, one of China's three national policy banks.
DHRM: 1.62 (-0.06)
Dehaier Medical Systems Showcases Its Wearable Sleep Respiratory Solution at Two Premier Sleep Conferences
GlobeNewswire - Wed Sep 02, 5:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it has showcased its wearable sleep respiratory product and solution at two premier sleep respiratory conferences, including: 1) the 4 National Sleep Respiratory Conference (the "NSRC" which took place in Shanghai; and 2) the 2 Sleep Medicine Annual Conference (the "SMAC" which took place in Qingdao City, Shandong Province.
DHRM: 1.62 (-0.06)
Dehaier Medical Systems Secures $2.44 Million Line of Credit
GlobeNewswire - Thu May 21, 7:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that the Company has secured a short-term line of credit with the Beijing branch of Nanjing Bank Company Limited ("Nanjing Bank" for up to RMB15 million (~$2.43 million), bearing a fixed rate of 7.8% per annum. The line of credit will be available for use as needed for general corporate purposes.
DHRM: 1.62 (-0.06)
Dehaier Medical Systems to Hold Investor Day on Mid June
GlobeNewswire - Wed May 13, 5:28AM CDT
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it will hold an Investor Day at 1:00 a.m. EDT on Friday June 12, 2015 (13:00 p.m. Beijing Time on June 12, 2015) in Beijing, to provide a presentation on the Company's performance, strategic goals and plans to grow its business.
DHRM: 1.62 (-0.06)
Dehaier Medical Systems Delivers Its Wearable Sleep Respiratory Solutions to Sonqao, a Physical Examination Chain
GlobeNewswire - Wed May 06, 7:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that its sleep respiratory solution systems have been adopted by Sonqao Health Checkup Institution ("Sonqao" , an emerging physical examination chain that provides comprehensive physical checkup and personalized health management services to over 200,000 patients annually through its three state-of-the-art physical examination centers in Beijing and Inner Mongolia.
DHRM: 1.62 (-0.06)
Dehaier Medical Systems Reports Full Year 2014 Financial Results
GlobeNewswire - Thu Apr 30, 5:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today reported its financial results for the fiscal year ended December 31, 2014.
DHRM: 1.62 (-0.06)
Dehaier Medical Systems discloses 2014 preliminary lower net income of USD1.3m
M2 - Mon Apr 13, 6:36AM CDT
Medical devices company Dehaier Medical Systems (NasdaqCM HRM) stated on Friday it anticipates net income of USD1.3m (USD0.23 per diluted share) for the fiscal year ended 31 December 2014.
DHRM: 1.62 (-0.06)
Dehaier Medical Systems Announces Unaudited Preliminary Full Year 2014 Financial Results
GlobeNewswire - Fri Apr 10, 7:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced selected preliminary, unaudited results for the fiscal year ended December 31, 2014.
DHRM: 1.62 (-0.06)
Dehaier Medical Systems Signs Strategic Cooperation Agreement With the Clinical Sleep Medicine Center of the Air Force General Hospital
GlobeNewswire - Wed Feb 11, 9:56AM CST
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it has signed a strategic cooperation agreement with the Clinical Sleep Medicine Center of the Air Force General Hospital (the "Hospital" to fully cooperate on sleep-related clinical research studies, sleep disease diagnosis and treatment, technology and equipment clinical tests, as well as public education and a sleep disorder awareness campaign. Established in October 1956 in Beijing, the Air Force General Hospital is one of the leading hospitals in China and an early adopter of Dehaier's wearable sleep respiratory solution systems as well.
DHRM: 1.62 (-0.06)
Dehaier Medical Systems Ltd. Cooperates with China Sciences Group (Holding) Co., Ltd. to Enter China's Elderly Sleep Apnea Market
PR Newswire - Thu Jul 07, 9:00AM CDT
Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier" or the "Company"
, which develops, markets and sells medical devices and wearable sleep respiratory products in China, announced on July 5, 2016 that it is partnering with China Sciences Group (Holding) Co., Ltd. ("China Sciences" to enter the Chinese pension and health industry by providing Dehaier's products through China Sciences' elder care platform. In connection with this announcement, Dehaier, China Sciences and another supplier, Chia Tai Pharmaceutical Group ("Chia Tai" , have signed a strategic cooperation agreement to launch the "Elderly Sleep Apnea Comprehensive Disease Solution Project" (the "Project" . The Project will leverage China Sciences' "Hui Kang" cloud-based health management platform to provide Dehaier's and Chia Tai's medical devices to the elderly. DHRM: 1.62 (-0.06)
Dehaier Medical Announces Receipt of the Nasdaq Notification Letter
PR Newswire - Mon May 23, 4:00PM CDT
Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier Medical" or the "Company"
, which develops, markets and sells medical devices and wearable sleep respiratory products in China and international markets, today announced that on May 18, 2016, the Listing Qualifications department of the Nasdaq Stock Market ("Nasdaq" sent the Company a notification letter (the "Nasdaq Letter" indicating that, as a result of the Company's failure to file its annual report on Form 20-F for the year ended December 31, 2015, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule" , which requires timely filing of periodic reports with the Securities and Exchange Commission. DHRM: 1.62 (-0.06)
Dehaier Medical Receives US$20 Million Strategic Investment from Liaison Interactive
PR Newswire - Thu Apr 28, 8:52AM CDT
Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier Medical" or the "Company"
, which develops, markets and sells medical devices and wearable sleep respiratory products in China and international markets, today announced that it entered into a definitive securities purchase agreement (the "Agreement" with Hangzhou Liaison Interactive Information Technology Co. Ltd. ("Liaison Interactive" or the "Purchaser" , a publicly listed company on the Shenzhen Stock Exchange (Trading Ticker: 002280) pursuant to which the Liaison Interactive has agreed to purchase 11,111,111 restricted common shares of the Company (the "Shares" for an aggregate of US$20,000,000 (the "Purchase Price" . The Purchase Price is US$1.80 per share, which represents a 35% premium to Dehaier Medical's closing price of $1.33 on April 27, 2016. DHRM: 1.62 (-0.06)
Dehaier Medical Systems Announces Preliminary Full Year 2015 Operating Results
PR Newswire - Fri Apr 08, 6:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier" or the "Company"
, which develops, markets and sells medical devices and wearable sleep respiratory products in China and international markets, today announced its selected preliminary, unaudited results for the fiscal year ended December 31, 2015. DHRM: 1.62 (-0.06)
Dehaier Medical Announces Corporate Restructuring Plan
PR Newswire - Fri Feb 05, 5:00AM CST
Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier Medical" or the "Company"
, which develops, markets and sells medical devices and wearable sleep respiratory products in China and international markets, today announced its corporate and business restructuring plan which aims to concentrate the Company's resources to develop its mobile health business, including wearable sleep respiratory business and to focus more on its major businesses. As of this announcement, the Company has officially launched the business and corporate restructuring process. DHRM: 1.62 (-0.06)
Dehaier Medical Announces the Results of 2015 Annual General Meeting
PR Newswire - Thu Dec 31, 5:00AM CST
Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier Medical" or the "Company"
, which develops, markets and sells medical devices and wearable sleep respiratory products in China and international markets, today announced the results of its 2015 annual general meeting of shareholders. The meeting, which was originally scheduled for December 29, 2015, was adjourned to 9:00 p.m., Eastern Standard Time, on Wednesday, December 30, 2015 in order to meet quorum requirements. DHRM: 1.62 (-0.06)
Continuous Positive Airway Pressure Devices Market 2016-2020
M2 - Mon Dec 07, 3:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/fdxm3v/continuous) has announced the addition of the "Continuous Positive Airway Pressure Devices Market 2016-2020" report to their offering. The global continuous positive airway pressure devices market is just budding and offers high growth opportunity, and hence is expected to progress with steady growth, posting a CAGR of nearly 7% during the forecast period. One of the major drivers of the market is high prevalence of sleep disorders. It is estimated that over 350 million people worldwide suffer from sleep apnea. Thus, the increasing awareness of sleep apnea and associated comorbid conditions such as high blood pressure, and obesity have led to increased demand for sleep apnea diagnostic and therapeutic devices. Similarly, advances in technology such as improved mask design, oral appliances, and use of oxygen devices are expected to provide support to continuous positive airway pressure users. A CPAP device is used to maintain a continuous level of PAP and is used to treat preterm babies whose lungs have not yet fully developed. CPAP devices comply with all age groups and are cost-effective, simple, and easy to use. This segment dominated the market with total market share of nearly 56% in 2015. The continuous positive airway pressure devices market is currently dominated by the Americas, accounting for a market share of almost 59%, followed by the EMEA region and the APAC region. In the Americas, the US was the largest revenue contributor because of the increased diagnosis of sleep apnea in patients. Key Topics Covered: PART 01: Executive summary PART 02: Scope of the report PART 03: Market research methodology PART 04: Introduction PART 05: Sleep apnea: An overview PART 06: Diseases linked to sleep apnea PART 07: Market landscape PART 08: Market segmentation by product type PART 09: Global CPAP devices market PART 10: Global CPAP accessories market PART 11: Geographical segmentation PART 12: Market drivers PART 13: Impact of drivers PART 14: Market challenges PART 15: Impact of drivers and challenges PART 16: Market trends PART 17: Vendor landscape PART 18: Key vendor analysis - ResMed - Philips Healthcare - Fisher & Paykel - 3B Medical - Apex Medical - Apria Healthcare - Armstrong Medical - BMC Medical - Bremed - Cardinal Health - Curative Medical - Dehaier Medical Systems - DeVilbiss Healthcare - Drager Medical - Genstar Technologies - Hans Rudolph - Heinen Lowenstein - Hersill - Heyer Medical - HOFFRICHTER GmbH - InnoMed Technologies - Intersurgical - Invacare - Medtronic - PAHSCO - Penlon - Pneumocare - Pulmodyne - Sleepnet - Smiths Medical - SOMNETICS - Sturdy Industrial - Weinmann Gerate fur Medizin. For more information visit http://www.researchandmarkets.com/research/fdxm3v/continuous
DHRM: 1.62 (-0.06), MDT: 88.36 (+0.87), IVC: 12.85 (+0.28)
Dehaier Medical Appoints Xiaoguang Shen to the Company's Board of Directors
PR Newswire - Tue Dec 01, 5:30AM CST
Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier Medical" or the "Company"
, which develops, markets and sells medical devices and wearable sleep respiratory products in China and international markets, today announced that it has appointed Xiaoguang Shen to the Company's Board of Directors. Mr. Shen will replace Yunxiang ("Phil" Fan and will serve his term until the meeting of the shareholders of the Registrant in 2015. Dehaier Medical's Board will remain at five members, with three independent directors. DHRM: 1.62 (-0.06)
Dehaier Medical Announces Date of Its 2015 Annual Meeting of Shareholders
PR Newswire - Mon Oct 26, 5:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier Medical" or the "Company"
, which develops, markets and sells medical devices and wearable sleep respiratory products in China and international markets, today announced its Annual Meeting of Shareholders will be held on December 29, 2015, at its executive offices at Suite 501, Jiuzhou Plaza, 83 Fuxing Road, Haidian District, Beijing, 100856, People's Republic of China. The record date for the Annual Meeting is November 23, 2015. The Company expects to mail its definitive proxy statement to all shareholders of record on or about November 25, 2015. DHRM: 1.62 (-0.06)
Dehaier Wins Medical Equipment Procurement Bid Financed by China Development Bank
PR Newswire - Mon Oct 19, 5:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier" or the "Company"
, which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it has won a medical device distribution bid for a new rural healthcare construction project supported by China Development Bank Corp ("CDB" . According to the agreement, Dehaier will provide its proprietary C-arm X-Ray machine and defibrillator monitor to Dongsheng Hospital of Ordos, Inner Mongolia. The procurement project is funded by CDB, one of China's three national policy banks. DHRM: 1.62 (-0.06)
Dehaier Medical Systems Showcases Its Wearable Sleep Respiratory Solution at Two Premier Sleep Conferences
GlobeNewswire - Wed Sep 02, 5:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it has showcased its wearable sleep respiratory product and solution at two premier sleep respiratory conferences, including: 1) the 4 National Sleep Respiratory Conference (the "NSRC" which took place in Shanghai; and 2) the 2 Sleep Medicine Annual Conference (the "SMAC" which took place in Qingdao City, Shandong Province. DHRM: 1.62 (-0.06)
Dehaier Medical Systems Secures $2.44 Million Line of Credit
GlobeNewswire - Thu May 21, 7:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that the Company has secured a short-term line of credit with the Beijing branch of Nanjing Bank Company Limited ("Nanjing Bank" for up to RMB15 million (~$2.43 million), bearing a fixed rate of 7.8% per annum. The line of credit will be available for use as needed for general corporate purposes. DHRM: 1.62 (-0.06)
Dehaier Medical Systems to Hold Investor Day on Mid June
GlobeNewswire - Wed May 13, 5:28AM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it will hold an Investor Day at 1:00 a.m. EDT on Friday June 12, 2015 (13:00 p.m. Beijing Time on June 12, 2015) in Beijing, to provide a presentation on the Company's performance, strategic goals and plans to grow its business. DHRM: 1.62 (-0.06)
Dehaier Medical Systems Delivers Its Wearable Sleep Respiratory Solutions to Sonqao, a Physical Examination Chain
GlobeNewswire - Wed May 06, 7:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that its sleep respiratory solution systems have been adopted by Sonqao Health Checkup Institution ("Sonqao" , an emerging physical examination chain that provides comprehensive physical checkup and personalized health management services to over 200,000 patients annually through its three state-of-the-art physical examination centers in Beijing and Inner Mongolia. DHRM: 1.62 (-0.06)
Dehaier Medical Systems Reports Full Year 2014 Financial Results
GlobeNewswire - Thu Apr 30, 5:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today reported its financial results for the fiscal year ended December 31, 2014. DHRM: 1.62 (-0.06)
Dehaier Medical Systems discloses 2014 preliminary lower net income of USD1.3m
M2 - Mon Apr 13, 6:36AM CDT
Medical devices company Dehaier Medical Systems (NasdaqCM
HRM) stated on Friday it anticipates net income of USD1.3m (USD0.23 per diluted share) for the fiscal year ended 31 December 2014. DHRM: 1.62 (-0.06)
Dehaier Medical Systems Announces Unaudited Preliminary Full Year 2014 Financial Results
GlobeNewswire - Fri Apr 10, 7:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced selected preliminary, unaudited results for the fiscal year ended December 31, 2014. DHRM: 1.62 (-0.06)
Dehaier Medical Systems Signs Strategic Cooperation Agreement With the Clinical Sleep Medicine Center of the Air Force General Hospital
GlobeNewswire - Wed Feb 11, 9:56AM CST
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company" , which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it has signed a strategic cooperation agreement with the Clinical Sleep Medicine Center of the Air Force General Hospital (the "Hospital" to fully cooperate on sleep-related clinical research studies, sleep disease diagnosis and treatment, technology and equipment clinical tests, as well as public education and a sleep disorder awareness campaign. Established in October 1956 in Beijing, the Air Force General Hospital is one of the leading hospitals in China and an early adopter of Dehaier's wearable sleep respiratory solution systems as well. DHRM: 1.62 (-0.06)
